<DOC>
	<DOCNO>NCT02148211</DOCNO>
	<brief_summary>The purpose pregnancy registry study detect describe abnormal pregnancy outcome woman intentionally unintentionally vaccinate GlaxoSmithKline ( GSK ) Biologicals ' seasonal Inactivated Influenza Vaccines ( sIIVs ) : Fluarix , FluLaval , Fluarix Quadrivalent FluLaval Quadrivalent .</brief_summary>
	<brief_title>Fluarix®/ FluLaval®/ Fluarix® Quadrivalent/ FluLaval® Quadrivalent Vaccine Pregnancy Registry</brief_title>
	<detailed_description>This study transition exist ongoing pregnancy registry Fluarix/ FluLaval/Fluarix Quadrivalent/ FluLaval Quadrivalent one post-authorization safety study ( PASS ) . Pregnancy outcome data collect use questionnaire within 3 month estimate date delivery ( EDD ) approximately 6 month 12 month EDD ( live birth ) ascertain presence birth defect diagnose , Q2 2014 Q2 2019 . The intent Registry prospectively collect data vaccination GSK sIIVs pregnancy within 28 day precede conception , potential confounding factor ( exposure medication ) information relate outcome pregnancy .</detailed_description>
	<criteria>A subject include Registry follow criterion meet : Exposure GSK sIIVs occur pregnancy within 28 day precede conception . Subject US resident . A HCP identify ( name , address phone number ) . Subject identify ( GSK HCP ) . Data register subject included analysis follow criterion meet : • Pregnancy ongoing outcome unknown time initial report . Data register subject included analysis follow criterion meet : • Outcome pregnancy know time initial report . Types know outcome include prenatal test report result abnormal outside reference range , indicate possible abnormality fetus . Pregnancies prenatal test indicate normal pregnancy would also exclude inclusion pregnancy could potentially bias result toward low overall estimate risk defect . Typically pregnancies &gt; 16 week gestation undergone prenatal test identify whether child congenital abnormality .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Fluarix Quadrivalent</keyword>
	<keyword>Fluarix</keyword>
	<keyword>FluLaval</keyword>
	<keyword>FluLaval Quadrivalent</keyword>
	<keyword>Pregnancy Registry</keyword>
	<keyword>Pregnancy outcome</keyword>
</DOC>